Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

07 nov. 2017 08h30 HE | Source: Collegium Pharmaceutical, Inc.

Collegium Receives FDA Approval for sNDA for Xtampza® ER

CANTON, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that the U.S. Food and Drug Administration (FDA) approved its Supplemental New Drug...
06 nov. 2017 08h45 HE | Source: Collegium Pharmaceutical, Inc.

Collegium Notified that the FDA Will Not Meet PDUFA Goal Date for sNDA for Xtampza® ER

CANTON, Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that the U.S. Food and Drug Administration (FDA) will not meet the prescription drug...
30 oct. 2017 16h01 HE | Source: Collegium Pharmaceutical, Inc.

Collegium to Host Conference Call to Discuss Third Quarter 2017 Financial Results and Provide Corporate Update

CANTON, Mass., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday,...
06 sept. 2017 07h00 HE | Source: Collegium Pharmaceutical, Inc

Collegium to Present at Upcoming Investor Conferences

CANTON, Mass., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that management will present at the following investor conferences in September: The...
05 sept. 2017 06h00 HE | Source: Collegium Pharmaceutical, Inc

Collegium Announces Scientific Presentations at PAINWeek 2017 Meeting

CANTON, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that it will present data on Xtampza® ER, an extended-release oral formulation of...
09 août 2017 16h01 HE | Source: Collegium Pharmaceutical, Inc

Collegium Reports Second Quarter Financial Results and Provides Corporate Update

Collegium strengthens leadership team with key additions to executive team and Board of DirectorsXtampza ER prescriptions grow by 34% in the second quarterXtampza ER Notice of Allowance granted and,...
18 juil. 2017 16h01 HE | Source: Collegium Pharmaceutical, Inc

Collegium to Host Conference Call to Discuss Second Quarter 2017 Financial Results and Provide Corporate Update

CANTON, Mass., July 18, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday, August...
08 juin 2017 16h01 HE | Source: Collegium Pharmaceutical, Inc

Collegium Announces Scientific Presentations at the 2017 International Conference on Opioids

CANTON, Mass., June 08, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that it will present data on Xtampza® ER, an extended-release oral formulation of...
01 juin 2017 07h00 HE | Source: Collegium Pharmaceutical, Inc

Collegium Announces Additional Managed Care Coverage for Xtampza ER for Medicare Part D Patients

CANTON, Mass., June 01, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that one of the largest managed care organizations with approximately 8 million Medicare...
30 mai 2017 16h10 HE | Source: Collegium Pharmaceutical, Inc

Collegium Announces the Appointment of Joseph Ciaffoni as Chief Operating Officer

CANTON, Mass., May 30, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the appointment of Joseph Ciaffoni to the newly created position of Executive Vice...

Page précédente